Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso

Background. A group A meningococcal (MenA) conjugate vaccine, PsA-TT (MenAfriVac), was introduced in Burkina Faso via mass campaigns between September and December 2010, targeting the 1- to 29-year-old population. This study describes specific antibody titers in the general population 11 months late...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Infect Dis
Asıl Yazarlar: Tall, Haoua, Yaro, Seydou, Kpoda, Hervé B. N., Ouangraoua, Soumeya, Trotter, Caroline L., Njanpop Lafourcade, Berthe-Marie, Findlow, Helen, Bai, Xilian, Martin, Catherine, Nwakamma, Ikenna, Ouedraogo, Jean Bosco, Gessner, Bradford D., Borrow, Ray, Mueller, Judith E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639492/
https://ncbi.nlm.nih.gov/pubmed/26553686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ519
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller